Company Number: 12450334

Analysis Date: 2025-07-19 12:42 UTC

1. Credit Opinion: DECLINE
   Resbite Ltd exhibits significant financial distress, with persistent and growing negative net assets and shareholders’ funds worsening from -£55,473 (2022) to -£63,195 (2023). The company’s current liabilities far exceed current assets, resulting in a sharply negative working capital position (-£14,979 in 2023). This indicates poor liquidity and inability to meet short-term obligations from operating cash flows. The absence of an audit and reliance on unaudited accounts further limits confidence. The company is a micro entity with minimal equity (£100 share capital) and a single director controlling 100% ownership, which concentrates risk. Given the financial trend and weak balance sheet, the company lacks the capacity to service debt reliably and is a credit risk.

2. Financial Strength:
   The balance sheet reveals a deteriorating financial position. Fixed assets are minimal (£362 in 2023) and dwindling cash reserves (£88). Current liabilities have increased to £15,091 while current assets fell to £112, resulting in a negative net current asset position. Long-term liabilities are substantial (£44,828). Shareholders’ funds are deeply negative, reflecting accumulated losses (£-63,295 P&L reserve). The company’s financial gearing is high, and there is no visible capital buffer. The trend from 2019 onwards shows steady erosion of net assets and working capital, indicating sustained losses and capital depletion.

3. Cash Flow Assessment:
   Liquidity is severely constrained. Cash at bank is negligible relative to creditors due within one year, exposing the company to risk of default on short-term liabilities. Debtors have drastically reduced from £1,882 in 2022 to £24 in 2023, signaling possible collection issues or reduced sales. Negative working capital and low cash balances imply insufficient operating cash flow to cover current obligations. The company’s ability to generate positive cash flows from operations appears limited, and it may be reliant on additional financing or capital injections to remain solvent.

4. Monitoring Points:

• Timeliness and completeness of statutory filings (noting the overdue confirmation statement as of 2024-02-06).
• Trends in working capital and cash balances in subsequent periods.
• Changes in director ownership or additional capital injections.
• Debtor collection performance and revenue generation signals from management updates.
• Any restructuring plans or evidence of improving profitability to restore net assets.